Search research articles
Contact Us
Filters
Showing results (321-330 of 333) with videos related to
Page
of 34
Sort By:
JAMA Cardiology
|
July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
Stephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
Kidney360
|
April 4, 2022
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort Study
Tania Salehi, Nicholas J Montarello, Nishant Juneja, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific region
Jian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Journal of Clinical Medicine
|
May 4, 2026
Evidence Map of Pharmacologic and Non-Pharmacologic Perioperative Strategies for Managing Acute Postoperative Pain After Laparoscopic Surgery, 2012-2025: The M-PALS Collaborative
Romil R Parikh, Gabriella L Lott, Miranda Considine, et al.
JACC. Asia
|
November 7, 2022
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
Hayato Tada, Khung Keong Yeo, Jian-Jun Li, et al.
Molecular Cancer Therapeutics
|
November 5, 2016
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Michael F Press, Catherine E Ellis, Robert C Gagnon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 6, 2014
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment
Sjoukje F Oosting, Adrienne H Brouwers, Suzanne C van Es, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 31, 2020
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, et al.
Nature Communications
|
November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
Gordon C Jayson, Cong Zhou, Alison Backen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies
Matthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 333) with videos related to
Sort By:
Page
of 34
JAMA Cardiology
|
July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
Stephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
Kidney360
|
April 4, 2022
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort Study
Tania Salehi, Nicholas J Montarello, Nishant Juneja, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific region
Jian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Journal of Clinical Medicine
|
May 4, 2026
Evidence Map of Pharmacologic and Non-Pharmacologic Perioperative Strategies for Managing Acute Postoperative Pain After Laparoscopic Surgery, 2012-2025: The M-PALS Collaborative
Romil R Parikh, Gabriella L Lott, Miranda Considine, et al.
JACC. Asia
|
November 7, 2022
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
Hayato Tada, Khung Keong Yeo, Jian-Jun Li, et al.
Molecular Cancer Therapeutics
|
November 5, 2016
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Michael F Press, Catherine E Ellis, Robert C Gagnon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 6, 2014
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment
Sjoukje F Oosting, Adrienne H Brouwers, Suzanne C van Es, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 31, 2020
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, et al.
Nature Communications
|
November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
Gordon C Jayson, Cong Zhou, Alison Backen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies
Matthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Page
of 34